0001062993-19-002518.txt : 20190605 0001062993-19-002518.hdr.sgml : 20190605 20190605135025 ACCESSION NUMBER: 0001062993-19-002518 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190603 FILED AS OF DATE: 20190605 DATE AS OF CHANGE: 20190605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CALDWELL PATRICK M CENTRAL INDEX KEY: 0001242121 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 19879342 MAIL ADDRESS: STREET 1: C/O PROTINE DESIGN LAB STREET 2: 532 BELLA CALAIS WAY CITY: SAN JOSE STATE: CA ZIP: 94138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2019-06-03 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001242121 CALDWELL PATRICK M C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 WILBUR STREET LYNBROOK NY 11563 0 1 0 0 Principal Financial Officer Common Stock, $0.001 par value 2019-06-03 4 S 0 6000 58.8 D 0 D The selling price of $58.80 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $58.50 to $59.19. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Patrick M. Caldwell, by Carl A. Valenstein, attorney-in-fact 2019-06-05